These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24862313)

  • 1. Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles.
    Buemi MR; De Luca L; Ferro S; Gitto R
    Arch Pharm (Weinheim); 2014 Aug; 347(8):533-9. PubMed ID: 24862313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological characterization of 3-substituted 1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Part 2.
    Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Chisari M; Ciranna L; Chimirri A
    J Med Chem; 2012 Dec; 55(23):10532-9. PubMed ID: 23140383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors.
    Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Costa L; Ciranna L; Prezzavento O; Arena E; Ronsisvalle S; Bruno G; Chimirri A
    J Med Chem; 2011 Dec; 54(24):8702-6. PubMed ID: 22050212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.
    Buemi MR; De Luca L; Chimirri A; Ferro S; Gitto R; Alvarez-Builla J; Alajarin R
    Bioorg Med Chem; 2013 Aug; 21(15):4575-80. PubMed ID: 23777828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
    Gitto R; De Luca L; Ferro S; Russo E; De Sarro G; Chisari M; Ciranna L; Alvarez-Builla J; Alajarin R; Buemi MR; Chimirri A
    Bioorg Med Chem; 2014 Feb; 22(3):1040-8. PubMed ID: 24411196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
    Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R
    Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
    Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
    Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
    Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From NMDA receptor antagonists to discovery of selective σ₂ receptor ligands.
    Gitto R; De Luca L; Ferro S; Scala A; Ronsisvalle S; Parenti C; Prezzavento O; Buemi MR; Chimirri A
    Bioorg Med Chem; 2014 Jan; 22(1):393-7. PubMed ID: 24290063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands.
    Nirogi RV; Badange R; Kambhampati R; Chindhe A; Deshpande AD; Tiriveedhi V; Kandikere V; Muddana N; Abraham R; Khagga M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7431-5. PubMed ID: 23141912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
    Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
    J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, Pharmacological Evaluation and Docking Studies of GluN2B-Selective NMDA Receptor Antagonists with a Benzo[7]annulen-7-amine Scaffold.
    Gawaskar S; Temme L; Schreiber JA; Schepmann D; Bonifazi A; Robaa D; Sippl W; Strutz-Seebohm N; Seebohm G; Wünsch B
    ChemMedChem; 2017 Aug; 12(15):1212-1222. PubMed ID: 28749574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor.
    Pessoa-Mahana H; González-Lira C; Fierro A; Zapata-Torres G; Pessoa-Mahana CD; Ortiz-Severin J; Iturriaga-Vásquez P; Reyes-Parada M; Silva-Matus P; Saitz-Barría C; Araya-Maturana R
    Bioorg Med Chem; 2013 Dec; 21(24):7604-11. PubMed ID: 24262884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
    Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
    J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
    Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
    J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
    Nirogi R; Dwarampudi A; Kambhampati R; Bhatta V; Kota L; Shinde A; Badange R; Jayarajan P; Bhyrapuneni G; Dubey PK
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4577-80. PubMed ID: 21724392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of the Benzylpiperidine Moiety with Fluorinated Phenylalkyl Side Chains for the Development of GluN2B Receptor Ligands.
    Thum S; Schepmann D; Kalinin DV; Ametamey SM; Wünsch B
    ChemMedChem; 2018 Dec; 13(23):2522-2529. PubMed ID: 30312542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
    Primofiore G; Settimo FD; Taliani S; Marini AM; Novellino E; Greco G; Lavecchia A; Besnard F; Trincavelli L; Costa B; Martini C
    J Med Chem; 2001 Jul; 44(14):2286-97. PubMed ID: 11428922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.